A precise and non-toxic treatment that targets lung cancer cells at the nanoscale is able to effectively kill the cells even at a low dose.
Researchers from Washington State University and the Department of Energy’s Pacific Northwest National Laboratory (PNNL) used tiny tubes made from organic molecules called peptoids to deliver cancer-killing drugs in a targeted manner. The research, led by Yuehe Lin, professor in WSU’s School of Mechanical and Materials Engineering, and Chun-Long Chen, a senior research scientist at PNNL and a joint faculty fellow at the University of Washington, was published as the cover story in the prestigious journal Small.
The biologically-inspired nanotubes, which are about a hundred thousand times thinner than a human hair, were rolled up from membrane-like nanosheets. The drug molecules, fluorescent dyes and cancer-targeting molecules were precisely placed within the nanotubes, enabling them to track the efficiency of drug delivery into the cancer cells.
The new technology allows the two drugs – one for chemotherapy and the other for a less-invasive photodynamic therapy treatment – to be delivered directly to the cancer cells. Photodynamic therapy uses a chemical that, when exposed to light, releases reactive oxygen species (ROS) that kill cancer cells. The researchers’ dual-drug approach enabled the use of a lower dose of the cancer drugs than using a single drug, leading to effective killing of cancer cells with low toxicity.
“By precisely engineering these nanotubes with fluorescent dyes and cancer targeting molecules, scientists can clearly locate tumor cells and track how the drug regimen is performing,” said Lin. “We can also track how nanotubes enter and deliver the drugs inside the cancer cell.”
The team tested the nanotubes on lung cancer cells and found that they delivered the chemotherapy drug doxorubicin directly into the fast-dividing cancer cells, resulting in highly efficient cancer killing while using less chemotherapy drugs.
“This is a promising approach for precision targeting with little damage to healthy surrounding cells,” said Lin.
While other nanomaterials, such as carbon nanotubes, have been used to deliver and track cancer-killing drugs, researchers have found that they are toxic to the body. Furthermore, they didn’t do well at precisely recognizing molecules.
“By using these peptoids, we were able to develop highly programmable nanotubes and a biocompatible delivery mechanism,” said Chen. “We also harnessed the high stability of peptoid and its well-controlled packing to develop nanotubes that are highly stable.”
“Due to their unique structure, these nanotubes can be easily assembled for use in cancer therapy and stay in the body longer for treatment,” said Lin.
The team is now looking for collaboration and funding opportunities with pharmaceutical companies to extend the research into animal and clinical studies.
The Latest on: Lung cancer
via Google News
The Latest on: Lung cancer
- LiquidLung Receives Notice of Allowance from U.S. Patent and Trademark Office, Unveils Novel RNA Technology for Non-Invasive Lung Cancer Detectionon December 7, 2021 at 10:00 am
Leading pulmonary disease company debuts to-be patented blood-based RNA technology platform with best-in-class sensitivity for early detection, confirmatory diagnosis and subtyping of lung ...
- Funding Keytruda for melanoma but not for lung cancer is racist, health advocates sayon December 7, 2021 at 8:00 am
Pharmac has been accused of institutional racism for funding drugs for melanoma, but not lung cancer – a disease that kills twice as many Māori and non-Māori.
- Valley oncologist urging lung cancer screening amid concerning rise in non-smokerson December 7, 2021 at 4:35 am
A Valley oncologist is recommending people get screened for lung cancer amid a concerning rise in cases among non-smokers.
- Demystifying lung canceron December 6, 2021 at 6:21 pm
LUNG cancer is a life-altering and devastating diagnosis, not just for the patient but his family members too. As with any cancer diagnosis, the patient will soon be flooded with well-meaning but ...
- New lung cancer report finds large disparities in prevention, treatment among races and ethnic groupson December 6, 2021 at 5:46 pm
The report delves into not just survival rates, prevention and treatment nationally, but also among different groups.
- Dr. Bestvina on Challenges With Interpreting Molecular Reports in Lung Canceron December 6, 2021 at 2:59 pm
Christine Bestvina, MD, assistant professor of medicine, Section of Hematology/Oncology, Department of Medicine, University of Chicago Medicine, discusses challenges with interpreting molecular ...
- 7 Signs You May Have Lung Cancer, Like Bob Doleon December 6, 2021 at 12:01 pm
Bob Dole, political icon, said in February he had been diagnosed with stage 4 lung cancer. On Sunday morning, he died at age 98. "It is with heavy hearts we announce that Senator Robert Joseph Dole ...
- Alabama residents least likely to survive lung cancer, report sayson December 4, 2021 at 5:00 am
A report from the American Lung Association found Alabama had the lowest survival rates for lung cancer five years after diagnosis out of 45 that provided data.
- GO2 Foundation for Lung Cancer Hires Joelle Fathi, DNP as Chief Healthcare Delivery Officeron December 2, 2021 at 3:10 am
SAN CARLOS, Calif. and WASHINGTON, Dec. 2, 2021 /PRNewswire/ -- GO2 Foundation for Lung Cancer (GO2 Foundation) has hired Joelle Fathi, DNP to ...
- Kathy Griffin Reveals She's Now Cancer-Free After Battling Lung Canceron December 1, 2021 at 7:56 am
Comedian Kathy Griffin, who announced her lung cancer diagnosis in August, revealed that she is free of the disease during an appearance on "Jimmy Kimmel Live." ...
via Bing News